OIM
Oracle Investment Management Portfolio holdings
AUM
$116M
This Quarter Return
+28.48%
1 Year Return
+84.31%
3 Year Return
+539.5%
5 Year Return
+791.07%
10 Year Return
+13,222.09%
AUM
$91.6M
AUM Growth
+$91.6M
(+41%)
Cap. Flow
+$13.3M
Cap. Flow
% of AUM
14.57%
Top 10 Holdings %
Top 10 Hldgs %
96.58%
Holding
23
New
3
Increased
4
Reduced
6
Closed
4
Top Buys
| 1 |
EyePoint Pharmaceuticals
EYPT
|
$9.28M |
| 2 |
SWTX
SpringWorks Therapeutics
SWTX
|
$5.73M |
| 3 |
Biohaven
BHVN
|
$4.66M |
| 4 |
Teladoc Health
TDOC
|
$2.43M |
| 5 |
Ardelyx
ARDX
|
$713K |
Top Sells
| 1 |
Pacific Biosciences
PACB
|
$2.57M |
| 2 |
GeneDx Holdings
WGS
|
$2.24M |
| 3 |
MannKind Corp
MNKD
|
$1.24M |
| 4 |
QuidelOrtho
QDEL
|
$1.08M |
| 5 |
NSTG
NanoString Technologies, Inc.
NSTG
|
$836K |
Sector Composition
| 1 | Healthcare | 99.81% |
| 2 | Energy | 0.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Biohaven
BHVN
$1.63B
| $30.7M | 18.65% |
716,427
+108,900
| +18% | +$4.66M |
|
|
2
Pacific Biosciences
PACB
$393M
| $13.5M | 8.21% |
1,376,795
-261,600
| -16% | -$2.57M |
|
|
3
QuidelOrtho
QDEL
$1.95B
| $13M | 7.91% |
176,544
-14,700
| -8% | -$1.08M |
|
|
4
EyePoint Pharmaceuticals
EYPT
$797M
| $9.28M | 5.64% |
+401,557
| New | +$9.28M |
|
|
SWTX
5
DELISTED
SpringWorks Therapeutics
SWTX
| $5.73M | 3.49% |
+157,083
| New | +$5.73M |
|
|
6
Ardelyx
ARDX
$1.53B
| $5.36M | 3.26% |
864,700
+115,000
| +15% | +$713K |
|
7
Forian
FORA
$61.3M
| $4M | 2.43% |
1,368,067
| – | – |
|
8
BioCryst Pharmaceuticals
BCRX
$1.74B
| $3.21M | 1.95% |
535,558
-19,964
| -4% | -$120K |
|
|
9
Teladoc Health
TDOC
$1.37B
| $2.43M | 1.48% |
+112,861
| New | +$2.43M |
|
|
IMMP
10
Immutep
IMMP
$234M
| $1.24M | 0.75% |
516,430
| – | – |
|
|
AGEN
11
Agenus
AGEN
$133M
| $1.17M | 0.71% |
1,416,963
-700,000
| -33% | -$580K |
|
12
Biogen
BIIB
$19.4B
| $624K | 0.38% |
2,412
| – | – |
|
|
13
GeneDx Holdings
WGS
$3.72B
| $490K | 0.3% |
178,354
-816,226
| -82% | -$2.24M |
|
|
AXDX
14
DELISTED
Accelerate Diagnostics
AXDX
| $437K | 0.27% |
111,575
-24,953
| -18% | -$97.8K |
|
|
VTNR
15
DELISTED
Vertex Energy, Inc
VTNR
| $170K | 0.1% |
50,000
+24,700
| +98% | +$83.7K |
|
16
Biodesix
BDSX
$62.6M
| $112K | 0.07% |
60,939
+18,863
| +45% | +$34.7K |
|
|
DMTK
17
DELISTED
DermTech, Inc. Common Stock
DMTK
| $83.5K | 0.05% |
47,687
| – | – |
|
18
MiNK Therapeutics
INKT
$64.4M
| $39.5K | 0.02% |
36,898
| – | – |
|
|
19
MannKind Corp
MNKD
$1.41B
| – | – |
-300,000
| Closed | -$1.24M |
|
20
Opko Health
OPK
$1.1B
| – | – |
-450,564
| Closed | -$721K |
|
|
WBA
21
DELISTED
Walgreens Boots Alliance
WBA
| – | – |
0
| – | – |
|
|
OMGA
22
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| – | – |
-50,000
| Closed | -$108K |
|
|
NSTG
23
DELISTED
NanoString Technologies, Inc.
NSTG
| – | – |
-485,886
| Closed | -$836K |
|